IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML

NCT06418776 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

198

Enrollment

NETWORK

Sponsor class

Conditions

Refractory Acute Myeloid Leukemia
Early Relapses of Acute Myeloid Leukemia

Interventions

OTHER: Intensive therapy
OTHER: Low intensity therapy

Sponsor

National Research Center for Hematology, Russia

Collaborators

[object Object]
[object Object]